Home / Inspections / 1021713

FDA Inspection 1021713 — South Texas Blood & Tissue Center

South Texas Blood & Tissue Center — FEI 1676815

The FDA completed an inspection of South Texas Blood & Tissue Center on June 15, 2017 in San Antonio, TX. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
June 15, 2017
Fiscal Year
2017
Product Type
Biologics
Project Area
Human Cellular, Tissue, and Gene Therapies
Location
San Antonio, TX (United States)

Facility

Other inspections at this facility

  • 1279560 (NAI Thu Aug 14 2025 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1172990 (NAI Thu Jun 09 2022 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1122018 (NAI Thu Feb 20 2020 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1117859 (VAI Fri Feb 14 2020 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1057467 (NAI Tue Jun 19 2018 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources